This week on LSCDS #ScienceNews and #Innovation:
Climate scientists call for action in “Climate tipping points — too risky to bet against”, detailing the evidence that suggests the planet is in a state of emergency.
Aurinia Pharmaceuticals, a Canadian biotech company, reported positive data for its lead drug in treating lupus nephritis. The Phase 3 clinical trial met all primary and secondary endpoints setting the stage to bring Voclosporin to market in 2020.
And, as immunotherapy programs are still booming in the biotech sphere, GEN Eng News highlights the Top 10 Immuno-Oncology Startup of 2019.